Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma (Q36384933)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
scientific article

    Statements

    Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma (English)
    Mads H Andersen
    Valeska Hofmeister-Müller
    Lidia Frey
    Christiane Sandig
    Steffen Walter
    Harpreet Singh-Jasuja
    Andreas Opitz
    8 May 2012
    2091-2103

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit